货号 | CAS号 |
---|---|
G129296-25mg | 1421783-64-3 |
G129296-5mg | 1421783-64-3 |
G126512-5mg | 1257628-77-5 |
G126512-100mg | 1257628-77-5 |
G126512-25mg | 1257628-77-5 |
溶解性 |
|
存贮条件 | 储存温度-20°C |
备注 | GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively. |
别名 | Benzamide, 4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]-, methanesulfonate (1:2);Benzamide, 4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]-, methanesulfonate (1:2) |